Drug

GLEMBATUMUMAB VEDOTIN

Drug TypeAction TypeMechanism of ActionApprovedMax Trial PhaseMax GBM Phase
Antibody BINDING AGENT Transmembrane glycoprotein NMB binding agent no 2 0